|Company Name||Clariant AG|
On February 14, 2022, Clariant disclosed that it would delay the release of its fourth quarter and full year 2021 financial results due to an internal “investigation into accounting matters related to the booking of provisions and accruals during the financial years 2020 and 2021.” Specifically, the investigation ”is reviewing whether employees incorrectly booked those provisions and accruals, with the aim of steering the Company’s results to meet internal and external targets.”
On this news, Clariant’s stock fell $3.47, or 14.6%, to close at $18.26 per share on February 14, 2022, thereby injuring investors.
Submit Your Information
If you suffered a loss on your Clariant AG investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.